| 15-Lipoxygenase and its metabolites in the pathogenesis of breast cancer: A double-edged sword MA Vaezi, B Safizadeh, AR Eghtedari, SS Ghorbanhosseini, M Rastegar, ... Lipids in Health and Disease 20, 1-19, 2021 | 25 | 2021 |
| Up-regulation of matrix metalloproteinase-9 in primary bone tumors and its association with tumor aggressiveness MA Vaezi, AR Eghtedari, B Safizadeh, G Ghasempour, V Salimi, ... Molecular Biology Reports 49 (10), 9409-9427, 2022 | 8 | 2022 |
| Evaluation of the expression pattern and diagnostic value of PPARγ in malignant and benign primary bone tumors AR Eghtedari, MA Vaezi, B Safizadeh, G Ghasempour, P Babaheidarian, ... BMC Musculoskeletal Disorders 23 (1), 746, 2022 | 8 | 2022 |
| The expression changes of PD-L1 and immune response mediators are related to the severity of primary bone tumors AR Eghtedari, MA Vaezi, E Safari, V Salimi, B Safizadeh, ... Scientific Reports 13 (1), 20474, 2023 | 4 | 2023 |
| Evaluating the local expression pattern of IGF-1R in tumor tissues and the circulating levels of IGF-1, IGFBP-1, and IGFBP-3 in the blood of patients with different primary … MA Vaezi, AR Eghtedari, B Safizadeh, P Babaheidarian, V Salimi, ... Frontiers in Oncology 12, 1096438, 2023 | 4 | 2023 |
| Functional and pathological role of 15-Lipoxygenase and its metabolites in pregnancy and pregnancy-associated complications AR Eghtedari, B Safizadeh, MA Vaezi, S Kalantari, M Tavakoli-Yaraki Prostaglandins & Other Lipid Mediators 161, 106648, 2022 | 4 | 2022 |
| The clinical significance of CD44v6 in malignant and benign primary bone tumors A Hosseini, AR Eghtedari, A Mirzaei, P Babaheidarian, S Nekoufar, ... BMC Musculoskeletal Disorders 24 (1), 607, 2023 | 2 | 2023 |
| AI-Based solutions for current challenges in regenerative medicine PA Sarabi, M Shabanpouremam, AR Eghtedari, M Barat, B Moshiri, ... European Journal of Pharmacology 984, 177067, 2024 | | 2024 |
| Investigating alterations in local and circulating expression profile and diagnostic value of IGF-1 axis and its related proteins in patients with osteosarcoma tumor MA Vaezi, AR Eghtedari, B Safizadeh, A Mirzaei, M Tavakoli-Yaraki | | |
Masoumeh Tavakoli-yarakiProfessor of Clinical Biochemistry at Iran University of medical sciences在 iums.ac.ir 的电子邮件经过验证
